Cigna Investments Inc Amgen Inc Transaction History

Cigna Investments Inc

  • $568 Million
  • Q3 2024

A detailed history of Cigna Investments Inc transactions in Amgen Inc stock. As of the latest transaction made, Cigna Investments Inc holds 5,531 shares of AMGN stock, worth $1.63 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
5,531
Previous 5,616 1.51%
Holding current value
$1.63 Million
Previous $1.75 Million 1.6%
% of portfolio
0.31%
Previous 0.32%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$309.38 - $337.38 $26,297 - $28,677
-85 Reduced 1.51%
5,531 $1.78 Million
Q2 2024

Jul 17, 2024
SELL
$262.75 - $319.31 $14,451 - $17,562
-55 Reduced 0.97%
5,616 $1.75 Million
Q1 2024

Apr 23, 2024
SELL
$268.87 - $324.56 $12,636 - $15,254
-47 Reduced 0.82%
5,671 $1.61 Million
Q4 2023

Jan 22, 2024
SELL
$255.7 - $288.46 $7,159 - $8,076
-28 Reduced 0.49%
5,718 $1.65 Million
Q3 2023

Oct 23, 2023
SELL
$218.65 - $271.46 $159,614 - $198,165
-730 Reduced 11.27%
5,746 $1.55 Million
Q2 2023

Aug 01, 2023
SELL
$214.27 - $253.37 $3,428 - $4,053
-16 Reduced 0.25%
6,476 $1.44 Million
Q1 2023

May 11, 2023
SELL
$225.79 - $275.2 $26,643 - $32,473
-118 Reduced 1.79%
6,492 $1.57 Million
Q4 2022

Feb 13, 2023
BUY
$229.03 - $291.01 $5,496 - $6,984
24 Added 0.36%
6,610 $1.74 Million
Q3 2022

Nov 14, 2022
SELL
$224.46 - $253.15 $89,784 - $101,260
-400 Reduced 5.73%
6,586 $1.49 Million
Q2 2022

Aug 15, 2022
SELL
$230.71 - $256.74 $670,904 - $746,599
-2,908 Reduced 29.39%
6,986 $1.7 Million
Q1 2022

May 13, 2022
SELL
$219.27 - $242.57 $651,231 - $720,432
-2,970 Reduced 23.09%
9,894 $2.39 Million
Q4 2021

Feb 14, 2022
SELL
$198.88 - $227.6 $921,013 - $1.05 Million
-4,631 Reduced 26.47%
12,864 $2.89 Million
Q3 2021

Nov 12, 2021
SELL
$212.27 - $248.7 $108,682 - $127,334
-512 Reduced 2.84%
17,495 $3.72 Million
Q2 2021

Aug 10, 2021
SELL
$233.58 - $259.14 $660,797 - $733,107
-2,829 Reduced 13.58%
18,007 $4.39 Million
Q1 2021

May 10, 2021
BUY
$221.91 - $258.6 $89,651 - $104,474
404 Added 1.98%
20,836 $5.18 Million
Q4 2020

Feb 11, 2021
BUY
$216.38 - $257.67 $304,663 - $362,799
1,408 Added 7.4%
20,432 $4.7 Million
Q3 2020

Nov 12, 2020
SELL
$234.65 - $260.95 $717,325 - $797,724
-3,057 Reduced 13.84%
19,024 $4.84 Million
Q2 2020

Aug 17, 2020
BUY
$197.81 - $242.74 $1.04 Million - $1.28 Million
5,259 Added 31.26%
22,081 $5.21 Million
Q1 2020

May 11, 2020
BUY
$182.24 - $241.7 $179,141 - $237,591
983 Added 6.21%
16,822 $3.41 Million
Q4 2019

Feb 04, 2020
SELL
$189.21 - $243.2 $361,769 - $464,998
-1,912 Reduced 10.77%
15,839 $3.42 Million
Q3 2019

Nov 07, 2019
SELL
$174.11 - $208.62 $221,816 - $265,781
-1,274 Reduced 6.7%
17,751 $3.79 Million
Q2 2019

Aug 12, 2019
SELL
$166.7 - $195.41 $160,365 - $187,984
-962 Reduced 4.81%
19,025 $3.55 Million
Q1 2019

May 10, 2019
BUY
$180.87 - $203.88 $89,349 - $100,716
494 Added 2.53%
19,987 $3.8 Million
Q4 2018

Feb 06, 2019
BUY
$178.4 - $208.25 $79,031 - $92,254
443 Added 2.33%
19,493 $3.79 Million
Q3 2018

Nov 13, 2018
SELL
$185.29 - $208.89 $1.9 Million - $2.14 Million
-10,231 Reduced 34.94%
19,050 $3.67 Million
Q2 2018

Aug 14, 2018
SELL
$166.05 - $186.51 $718,000 - $806,469
-4,324 Reduced 12.87%
29,281 $5.41 Million
Q1 2018

May 09, 2018
SELL
$169.43 - $198.0 $238,726 - $278,982
-1,409 Reduced 4.02%
33,605 $5.73 Million
Q4 2017

Jan 26, 2018
SELL
$168.79 - $188.59 $202,548 - $226,308
-1,200 Reduced 3.31%
35,014 $6.09 Million
Q3 2017

Oct 11, 2017
BUY
$167.29 - $191.0 $6.06 Million - $6.92 Million
36,214
36,214 $6.75 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cigna Investments Inc Portfolio

Follow Cigna Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Cigna Investments Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email